SEER Inquiry System - Home
Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.
|
|||||||
|---|---|---|---|---|---|---|---|
| Add to Report | ID | Question | Status | Last Updated | |||
| 20120039 | Primary site/Heme & Lymphoid Neoplasms: What site do I code this to and what rule applies? How did you arrive at this? Please advise. See discussion. | Final | May 11 2012 | ||||
| 20120038 | Histology/Heme & Lymphoid Neoplasms: Is there a relevant term to code this case? A diagnostic report indicates Monoclonal B Lymphocytosis of Uncertain Significance (MLUS), not Monoclonal Gammopathy of Undetermined Significance (MGUS). This term is not referenced in ICDO or SEER Heme database. |
Final | May 11 2012 | ||||
| 20120037 | Primary site/Heme & Lymphoid Neoplasm: What is the topography code for Primary Effusion Lymphoma? Patient had pleural and pericardial effusion and pleural fluid was positive for Lymphoma. | Final | May 11 2012 | ||||
| 20120036 | Primary site/Heme & Lymphoid Neoplasms: Would the primary site be coded to C809 or C779? Patient with known mantle cell lymphoma in history on path report. Bone marrow biopsy read at my facility without involvement of bone marrow. There is no information concerning where lymphoma originated. |
Final | May 11 2012 | ||||
| 20120035 | Reportability--Pancreas: Are well differentiated pancreatic endocrine neoplasms (PanNETs) reportable? If so, what is the histology code? | Final | Apr 05 2012 | ||||
| 20120034 | Primary site--Brain and CNS: What is the correct site/subsite code? MRI states: left cerebellar venous angioma. According to the WHO Classification of brain/cns tumors, code 9122/0 does not appear under tumors of the cerebellum (C71.6) | Final | May 11 2012 | ||||
| 20120033 | Multiple primaries--Heme & Lymphoid Neoplasms: Is this a single primary (Essential thrombocyhemia)? The patient was originally diagnosed in 2007 with essential thrombocythemia and treated with Hydrea. On 12/4/09 the patient had a bone marrow biopsy showing primary myelofibrosis which the physician states is a transition from the essential thrombocythemia. I could not find reference to this in the rules, and the database calls this 2 primaries? Please advise. |
Final | Mar 02 2012 | ||||
| 20120032 | MP/H Rules/Histology--Melanoma: How is the histology coded for an invasive melanoma stated to have a “superficial spreading growth pattern”? See discussion. | Final | Mar 12 2012 | ||||
| 20120031 | Grade--Bladder: How is grade coded for an invasive urothelial carcinoma of the bladder that is stated to be “histologic grade (WHO/ISUP): high grade”? See discussion. | Final | Mar 12 2012 | ||||
| 20120030 | MP/H Rules/Histology--Melanoma: What is the correct histology code for a case in which the final diagnosis for an excisional biopsy specimen is reported as “malignant melanoma, superficial spreading type” and in the CAP protocol layout within the same report indicates that the “cell type: epithelioid”? See discussion. | Final | Mar 12 2012 | ||||
|
|||||||
